Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Pupillo

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Methods and Protocols|September 23, 2024
The Burden of Sleep/Wake Disorders: Excessive Daytime Sleepiness and Insomnia ProjectMarina Tüzün, Ulf Kallweit, Stefan Seidel, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 15, 2013
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onsetLucio Tremolizzo, Paolo Messina, Elisa Conti, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 12, 2010
The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trialsEttore Beghi, Adriano Chiò, Philippe Couratier, et al.
Journal of the Neurological Sciences|March 5, 2026
Response to comments to "Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis"Elisabetta Pupillo, Maurizio A Leone, Antony Amato, et al.
Journal of the Neurological Sciences|January 6, 2026
Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysisElisabetta Pupillo, Maurizio A Leone, Anthony Amato, et al.
Journal of the Neurological Sciences|February 17, 2026
Response to comments to "Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis"Elisabetta Pupillo, Maurizio A Leone, Antony Amato, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 21, 2013
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALSEttore Beghi, Elisabetta Pupillo, Virginio Bonito, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 26, 2020
Focus on the heterogeneity of amyotrophic lateral sclerosisCaterina Bendotti, Valentina Bonetto, Elisabetta Pupillo, et al.
Annals of Neurology|April 8, 2014
Physical activity and amyotrophic lateral sclerosis: a European population-based case-control studyElisabetta Pupillo, Paolo Messina, Giorgia Giussani, et al.
Journal of Neurology|September 9, 2021
Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019Alberto Raggi, Lorenzo Monasta, Ettore Beghi, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Methods and Protocols|September 23, 2024
The Burden of Sleep/Wake Disorders: Excessive Daytime Sleepiness and Insomnia ProjectMarina Tüzün, Ulf Kallweit, Stefan Seidel, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 15, 2013
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onsetLucio Tremolizzo, Paolo Messina, Elisa Conti, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 12, 2010
The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trialsEttore Beghi, Adriano Chiò, Philippe Couratier, et al.
Journal of the Neurological Sciences|March 5, 2026
Response to comments to "Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis"Elisabetta Pupillo, Maurizio A Leone, Antony Amato, et al.
Journal of the Neurological Sciences|January 6, 2026
Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysisElisabetta Pupillo, Maurizio A Leone, Anthony Amato, et al.
Journal of the Neurological Sciences|February 17, 2026
Response to comments to "Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis"Elisabetta Pupillo, Maurizio A Leone, Antony Amato, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 21, 2013
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALSEttore Beghi, Elisabetta Pupillo, Virginio Bonito, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 26, 2020
Focus on the heterogeneity of amyotrophic lateral sclerosisCaterina Bendotti, Valentina Bonetto, Elisabetta Pupillo, et al.
Annals of Neurology|April 8, 2014
Physical activity and amyotrophic lateral sclerosis: a European population-based case-control studyElisabetta Pupillo, Paolo Messina, Giorgia Giussani, et al.
Journal of Neurology|September 9, 2021
Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019Alberto Raggi, Lorenzo Monasta, Ettore Beghi, et al.
Pageof 6